FLUOROURACIL - BIOCHEMISTRY AND PHARMACOLOGY

被引:787
作者
PINEDO, HM [1 ]
PETERS, GFJ [1 ]
机构
[1] FREE UNIV HOSP AMSTERDAM,DEPT ONCOL,POB 7057,1007 MB AMSTERDAM,NETHERLANDS
关键词
D O I
10.1200/JCO.1988.6.10.1653
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1653 / 1664
页数:12
相关论文
共 61 条
[1]  
BAPAT AR, 1983, J BIOL CHEM, V258, P4130
[2]  
BERGER SH, 1984, MOL PHARMACOL, V25, P303
[3]   CONTINUOUS 5-DAY REGIONAL CHEMOTHERAPY BY 5-FLUOROURACIL IN COLON-CARCINOMA - PHARMACOKINETIC EVALUATION [J].
BOUBLIL, JL ;
MILANO, G ;
KHATER, R ;
BOURRY, J ;
THYSS, A ;
BRUNETON, JN ;
RENEE, N ;
PHILIP, C ;
NAMER, M .
BRITISH JOURNAL OF CANCER, 1985, 52 (01) :15-20
[4]  
BROCKMAN RW, 1977, CANCER, V40, P2681, DOI 10.1002/1097-0142(197711)40:5+<2681::AID-CNCR2820400941>3.0.CO
[5]  
2-E
[6]  
CHABNER BA, 1982, PHARM PRINCIPLES CAN, P183
[8]   NON-LINEAR PHARMACOKINETIC MODELS FOR 5-FLUOROURACIL IN MAN - INTRAVENOUS AND INTRAPERITONEAL ROUTES [J].
COLLINS, JM ;
DEDRICK, RL ;
KING, FG ;
SPEYER, JL ;
MYERS, CE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :235-246
[9]   THYMIDYLATE SYNTHETASE - TARGET ENZYME IN CANCER CHEMOTHERAPY [J].
DANENBERG, PV .
BIOCHIMICA ET BIOPHYSICA ACTA, 1977, 473 (02) :73-92
[10]  
DANENBERG PV, 1982, MOL CELL BIOCHEM, V43, P49